Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Tuberous Sclerosis Complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's Disease.

Adriaanse BA. et al, (2023), Neuropathol Appl Neurobiol

Microglia directly associate with pericytes in the central nervous system.

Morris GP. et al, (2023), Glia

A potential protective role of the nuclear receptor-related factor 1 (Nurr1) in multiple sclerosis motor cortex: a neuropathological study

Pansieri J. et al, (2023), Brain Communications, 5

Anterior optic pathway pathology in CNS demyelinating diseases

Pisa M. et al, (2022), Brain, 145, 4308 - 4319

Microglia associations with brain pericytes and the vasculature are reduced in Alzheimer’s disease

Morris GP. et al, (2022)

Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis

Pisa M. et al, (2022), Multiple Sclerosis and Related Disorders, 63, 103917 - 103917

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Kaufmann M. et al, (2022), Nature Neuroscience

Histopathological Characterization of Staged Lesion Topography in the Multiple Sclerosis Spinal Cord

Waldman AD. et al, (2022)

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).

Dobson R. et al, (2022), Mult Scler Relat Disord, 63

Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.

Zhu WM. et al, (2022), Brain

Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death.

Hadley G. et al, (2022), J Neurol Neurosurg Psychiatry

Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?

Spencer JI. et al, (2022), Journal of the Neurological Sciences, 432, 120056 - 120056

The influence of HLA-DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter.

Yates RL. et al, (2021), Brain Pathol

Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach.

Yeo T. et al, (2021), Brain Commun, 3, fcab240 - fcab240

An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue

Tackley G. et al, (2021), NeuroImage, 238, 118225 - 118225

Contemporary Neuroscience Core Curriculum for Medical Schools.

Gelb DJ. et al, (2021), Neurology

Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks.

Sadovnick AD. et al, (2021), Mult Scler

Natalizumab‐induced acquired perforating dermatosis

Fisher RM. et al, (2021), Clinical and Experimental Dermatology

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.

Messina S. et al, (2021), Mult Scler Relat Disord, 49

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application

Yeo T. et al, (2020), Scientific Reports, 10

Load More

1
2
3
4
5
6
7

Include forthcoming?